Kida K, Hatanaka D, Minami M, Suzuki T, Iwakami M, Kobayashi M, Hayashi H, Kawahara H, Horikawa M, Kanaki T. Simple chitin-based cell culture platform for production of biopharmaceuticals.
Biotechnol Lett 2023;
45:1265-1277. [PMID:
37606752 DOI:
10.1007/s10529-023-03422-7]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Accepted: 07/19/2023] [Indexed: 08/23/2023]
Abstract
OBJECTIVES
Gene therapy using viral vectors and antibody-based therapies continue to expand within the pharmaceutical market. We evaluated whether Cellhesion® VP, a chitin-based material, can be used as 3D culture platform for cell lines used for the production of antibodies and viral vectors.
RESULTS
The results of Cell Counting Kit-8 assay and LDH assay revealed that Cellhesion® VP had no adverse effect to Human Embryonic Kidney (HEK) 293, A549 and Chinese hamster ovary (CHO) DG44-Interferon-β (IFN) cells. Cell growth analyses showed that Cellhesion® VP supported the 3D culture of HEK293, A549 and CHO DG44- IFN-β cells with a spherical morphology. Importantly, subculture of these cell lines on Cellhesion® VP was easily performed without trypsinization because cells readily transferred to newly added scaffold. Our data also suggest that CHO DG44-IFNβ, cultured on Cellhesion® VP secreted IFNβ stably and continuously during the culture period.
CONCLUSIONS
Cellhesion® VP provides a simple and streamlined expansion culture system for the production of biopharmaceuticals.
Collapse